EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A CRISPR/Cas9‐based method for targeted DNA methylation enables cancer initiation in B lymphocytes

Shota Katayama iD, Koichi Shiraishi, Naoki Gorai, Masao Andou

Advanced Genetics · 2021

DOI: 10.1002/ggn2.10040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Genetics, 2021. Verfasst von Shota Katayama und 3 weiteren Autor:innen. Beteiligte Einrichtung: IMRA Japan Co., Ltd. Sapporo Japan. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted DNA methylation is important for understanding transcriptional modulation and epigenetic diseases. Although CRISPR‐Cas9 has potential for this purpose, it has not yet been successfully used to efficiently introduce DNA methylation and induce epigenetic diseases. We herein developed a new system that enables the replacement of an unmethylated promoter with a methylated promoter through microhomology‐mediated end joining‐based knock‐in. We successfully introduced an approximately 100% DNA methylation ratio at the cancer‐associated gene SP3 in HEK293 cells. Moreover, engineered SP3 promoter hypermethylation led to transcriptional suppression in human B lymphocytes and induced B‐cell lymphoma. Our system provides a promising framework for targeted DNA methylation and cancer initiation through epimutations.

Schlagwörter

Stichwörter der Autor:innen

CRISPR/Cas9DNA methylationMMEJcancer initiationcancer risk evaluationgene expression

Autor:innen und Institutionen

  • IMRA Japan Co., Ltd. Sapporo Japan.
  • AISIN AW Co., Ltd. Anjou Japan.

ORCID-Profile: Shota Katayama

Zitieren

APA

Katayama, S., Shiraishi, K., Gorai, N., & Andou, M. (2021). A CRISPR/Cas9‐based method for targeted DNA methylation enables cancer initiation in B lymphocytes. Advanced Genetics. https://doi.org/10.1002/ggn2.10040

Vancouver

Katayama S, Shiraishi K, Gorai N, Andou M. A CRISPR/Cas9‐based method for targeted DNA methylation enables cancer initiation in B lymphocytes. Advanced Genetics. 2021. doi:10.1002/ggn2.10040

BibTeX
@article{Katayama2021,
  author = {Katayama, Shota and Shiraishi, Koichi and Gorai, Naoki and Andou, Masao},
  title = {A CRISPR/Cas9‐based method for targeted DNA methylation enables cancer initiation in B lymphocytes},
  journal = {Advanced Genetics},
  year = {2021},
  doi = {10.1002/ggn2.10040}
}
Kostenlos starten →